Figure 1: Levels of markers of inflammation (A–C), bone turnover markers (D–I) and adipokines (J–L) under treatment with TNF inhibitors: serum levels at baseline (BL; before start of TNFi), after 3 months (3m) and 2 years (2y) of treatment. Wilcoxon Signed Rank Test: *p value <0.05; **p value <0.01; ***p value <0.001